CSOP Hang Seng Biotech ETF (03174.HK) Fell 2.24% to 3.310
Newtimespace News, as of 15:04 on May 15, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 3.310, down 2.24%. The ETF opened at HKD 3.398, with a high of HKD 3.398 and a low of HKD 3.286. The latest Net Asset Value (NAV) per unit is HKD 3.394, with a premium rate of -0.22%. The asset size is approximately HKD 862 million.
CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of biotechnology companies listed in Hong Kong, covering companies in sectors such as pharmaceuticals, biotechnology, and healthcare equipment. It serves as one of the important market benchmarks reflecting the performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HERBS GROUP (02593.HK): Change of Company Secretary and Authorised Representative
- TRAVEL EXPERT (01235.HK): Subscribes US$1.31m Wealth Product in Discloseable Transaction
- SA SA INT'L (00178.HK): HK & Macau Offline Sales Up Over 60% Year-on-Year in National Day Holiday
- SPT ENERGY (01251.HK): BET-X Exploration Well in Indonesia's Jabung Tengah Block Reaches Total Depth of 9,032 Feet
- CCT FORTIS (00138.HK): Appoints Yuen Wai Kin as Non-executive Director at HKD 10,000 Monthly